Sleep New Clinical Guideline Recommendations for Sleep Disorders that Cause Excessive Sleepiness August 6, 2021 RTSleepWorld Read Article
Sleep Pharmaceuticals Jazz Presents Phase 3 Results of Xywav in Adults with Idiopathic Hypersomnia April 23, 2021 RTSleepWorld Read Article
Pharmaceuticals Jazz Gets FDA Approval of Xywav for Narcolepsy Related Cataplexy or EDS July 23, 2020 RTSleepWorld Read Article
Pharmaceuticals FDA Approves DAYVIGO for Treatment of Insomnia in Adults December 27, 2019 RTSleepWorld Read Article
Pharmaceuticals First Non-Scheduled Narcolepsy Treatment Coming Soon August 16, 2019 RTSleepWorld Read Article
Patient Care I’m A CPAP Dropout: Why Many Lose Sleep Over Apnea Treatment July 19, 2019 RTSleepWorld Read Article
Pharmaceuticals Jazz Pharmaceuticals Announces FDA Approval of Sunosi for EDS and OSA March 22, 2019 RTSleepWorld Read Article
Pharmaceuticals Jazz Receives New PDUFA Goal Date for Solriamfetol for EDS Associated with Narcolepsy or OSA December 28, 2018 RTSleepWorld Read Article
Pharmaceuticals Promising Data for First New Narcolepsy Drug in Ten Years, Pending Approval September 21, 2018 RTSleepWorld Read Article